Evidence map›Paper›PMID 38363456›Full record

ArticleGenes & genomics2024

A rare TNNT1 gene variant causing creatine kinase elevation in nemaline myopathy: c.271_273del (p.Lys91del).

Cüneyd Yavaş, Mustafa Doğan, Recep Eröz, Kübra Türegün

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Genes & genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. A homozygous single-nucleotide variant inJournal of neuromuscular diseases · 2025
    Article
  3. Article
  4. The Evaluation of the Genetic Variation Types of theGenetic testing and molecular biomarkers · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Cüneyd YavaşDepartment of Molecular Biology and Genetics, Biruni University, Karanfil St. No:1H/12, Beylikduzu, Istanbul, 34100, Turkey. cyavas@biruni.edu.tr.ORCID 0000-0002-1597-5922
Mustafa DoğanGenetic Diseases Assessment Center, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Recep ErözDepartment of Medical Genetics Medical Faculty, Aksaray University, Aksaray, Turkey.
Kübra TüregünDepartment of Biotechnology, Institute of Science and Technology, Yıldız Technical University, Istanbul, Turkey.
Aksaray University · TRBiruni University · TRİstanbul Başakşehir Çam ve Sakura Şehir HastanesiYıldız Technical University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNemaline Myopathy (NM) is a rare genetic disorder that affects muscle function and is characterized by the presence of nemaline rods in muscle fibers. These rods are abnormal structures that interfere with muscle contraction and can cause muscle weakness, respiratory distress, and other complications. NM is caused by variants in several genes, including TNNT1, which encodes the protein troponin T1. NM is inherited in an autosomal recessive pattern. The prevalence of heterozygous TNNT1 variants has been reported to be 1/152,000, indicating that the disease is relatively rare.

objectiveInvestigation of TNNT1 gene variants that may cause cretin kinase elevation.

methodsDetailed family histories and clinical data were recorded. Whole exome sequencing was performed and family segregation was done by Sanger sequencing.

resultsIn this study, we report a 5-year-old girl with a novel variant recessive congenital TNNT1 myopathy. The patient had a novel homozygous (c.271_273del) deletion in the TNNT1 gene that is associated with creatine kinase elevation, which is a marker of muscle damage.

conclusionThis case expands the phenotypic spectrum of TNNT1 myopathy and highlights the importance of genetic testing and counseling for families affected by this rare disorder. In this study provides valuable insights into the genetic basis of NM and highlights the importance of early diagnosis and management for patients with this rare disorder. Further research is needed to better understand the pathophysiology of TNNT1 myopathy and to develop effective treatments for this debilitating condition.

Indexed as

Myopathies, NemalineChild, PreschoolCreatine KinaseFemaleGenetic TestingHomozygoteHumansTroponin TCreatine KinaseTroponin TAmish nemaline myopathyCreatine kinaseMuscle lossTNNT1Whole exome sequence

Identifiers

PMID38363456
OpenAlexW4391883553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.